133 related articles for article (PubMed ID: 15755268)
1. Endoscopy-negative reflux disease: part of the spectrum of gastro-oesophageal reflux disease [corrected] or a separate disorder? Implications for treatment.
Galmiche JP
Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():9-10, 21-4. PubMed ID: 15755268
[No Abstract] [Full Text] [Related]
2. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression.
Malfertheiner P; Fass R; Quigley EM; Modlin IM; Malagelada JR; Moss SF; Holtmann G; Goh KL; Katelaris P; Stanghellini V; Talley NJ; Tytgat GN; Wright NA
Aliment Pharmacol Ther; 2006 Mar; 23(6):683-90. PubMed ID: 16556170
[TBL] [Abstract][Full Text] [Related]
3. [Are dyspepsia or gastroesophageal reflux predictive of serious digestive events during treatment with NSAIDs? How should they be treated?].
Abitbol V; Chaussade S
Presse Med; 2003 Nov; 32(37 Pt 2):S53-5. PubMed ID: 14763356
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
6. Review article: quality-of-life issues in gastro-oesophageal reflux disease.
Quigley EM; Hungin AP
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():41-7. PubMed ID: 16042658
[TBL] [Abstract][Full Text] [Related]
7. [The otolaryngological manifestations of gastroesophageal reflux disease].
Tall A; Diop EM
Dakar Med; 2008; 53(2):142-9. PubMed ID: 19634550
[TBL] [Abstract][Full Text] [Related]
8. [NSAID administration and esophageal pathology: interaction with gastroesophageal reflux disease (GERD) symptoms, risk factors and incidence of erosive esophagitis].
Karateev AE; Uspenskiĭ IuP; Pakhomova IG; Nasonov EL
Eksp Klin Gastroenterol; 2008; (3):11-6. PubMed ID: 19145877
[No Abstract] [Full Text] [Related]
9. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
[TBL] [Abstract][Full Text] [Related]
10. Definitions and classification of dyspepsia: pH, Helicobacter pylori, non-steroidal anti-inflammatory drugs--should we include gastro-oesophageal reflux disease?
Bazzoli F
Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():15-6, 21-4. PubMed ID: 15755270
[No Abstract] [Full Text] [Related]
11. [Endoscopic treatment of gastro-esophageal reflux disease].
Weigert N; Neuhaus H; Rösch T
Dtsch Med Wochenschr; 2002 May; 127(22):1204-9. PubMed ID: 12035118
[No Abstract] [Full Text] [Related]
12. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
Bretagne JF; Rey JF; Caekaert A; Barthélemy P
Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
Ruszniewski P; Soufflet C; Barthélémy P
Aliment Pharmacol Ther; 2008 Nov; 28(9):1134-9. PubMed ID: 18671778
[TBL] [Abstract][Full Text] [Related]
15. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
16. Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.
Oudkerk Pool M
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():13-6. PubMed ID: 18081644
[TBL] [Abstract][Full Text] [Related]
17. EndoCinch treatment for gastro-oesophageal reflux disease.
Mahmood Z; Ang YS
Digestion; 2007; 76(3-4):241-7. PubMed ID: 18176078
[TBL] [Abstract][Full Text] [Related]
18. Impact of referral for gastro-oesophageal reflux disease on the workload of an academic Gastroenterology Unit.
Cantù P; Savojardo D; Carmagnola S; Penagini R
Dig Liver Dis; 2005 Oct; 37(10):735-40. PubMed ID: 16024304
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of gastro-oesophageal reflux disease: is the bottle half-full or half-empty?
Zeitoun P
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):361-2. PubMed ID: 9789127
[No Abstract] [Full Text] [Related]
20. [Heartburn: gastro-oesophageal reflux in 9 pictures].
Buset M; Demanet E
Rev Med Brux; 2008; 29(3):197-205. PubMed ID: 18705604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
